Cargando…

Understanding Vaccine Safety and the Roles of the FDA and the CDC

Detalles Bibliográficos
Autor principal:	Meissner, H. Cody
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069993/ https://www.ncbi.nlm.nih.gov/pubmed/35476652 http://dx.doi.org/10.1056/NEJMra2200583

Ejemplares similares

FDA and CDC recommend resuming use of Janssen COVID-19 vaccine
Publicado: (2021)

The menacing assaults on science, FDA, CDC, and health of the US public
por: Alter, Scott M., et al.
Publicado: (2020)

Immunology careers at the NIH, FDA and CDC: different paths that focus on advancing public health
por: Catalfamo, Marta, et al.
Publicado: (2015)

Awareness and trust of the FDA and CDC: Results from a national sample of US adults and adolescents
por: Kowitt, Sarah D., et al.
Publicado: (2017)

Toward an understanding of the Cdc48/p97 ATPase
por: Bodnar, Nicholas, et al.
Publicado: (2017)

Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank
por: Paulick, Ashley, et al.
Publicado: (2021)

Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines
por: Hargrave, Anna, et al.
Publicado: (2023)

Understanding the new FDA pregnancy and lactation labeling rules()
por: Blattner, Collin M., et al.
Publicado: (2016)

The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response
por: Myers, Tanya R., et al.
Publicado: (2023)

Avoiding future controversies in the Alzheimer’s disease space through understanding the aducanumab data and FDA review
por: Dickson, Samuel P., et al.
Publicado: (2023)

EPH174 Adverse Events Associated with COVID-19 and Seasonal Influenza Vaccines: A Retrospective and Descriptive Analysis of CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Reports
por: Alqahtani, Z, et al.
Publicado: (2022)

FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022)

The FDA's Final Rule on Expedited Safety Reporting: Statistical Considerations
por: Wittes, Janet, et al.
Publicado: (2015)

2017 FDA Peptide Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2018)

2018 FDA Tides Harvest
por: Al Shaer, Danah, et al.
Publicado: (2019)

FDA Approvals of Biologics in 2022
por: Martins, Alexander C., et al.
Publicado: (2023)

FDA and Its Role in Drug Development
por: Pazdur, Richard
Publicado: (2021)

Correction for Paulick et al., “Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank”
por: Paulick, Ashley, et al.
Publicado: (2022)

Limiting lumens: a new role for Cdc42
por: Lechler, Terry
Publicado: (2008)

Regulation of immunotherapeutic products for cancer and FDA’s role in product development and clinical evaluation
por: Vatsan, Ramjay S, et al.
Publicado: (2013)

First vaccine approval under the FDA Animal Rule
por: Beasley, David W C, et al.
Publicado: (2016)

Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines
por: McMurry, Reid, et al.
Publicado: (2021)

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
por: Namiot, Eugenia D., et al.
Publicado: (2023)

First COVID-19 Vaccines Receiving the US FDA and EMA Emergency Use Authorization
por: Fortner, Andra, et al.
Publicado: (2021)

The Multiple Roles of the Cdc14 Phosphatase in Cell Cycle Control
por: Manzano-López, Javier, et al.
Publicado: (2020)

The Role of Real‐World Evidence in FDA‐Approved New Drug and Biologics License Applications
por: Purpura, Christina A., et al.
Publicado: (2021)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
por: Dhuguru, Jyothi, et al.
Publicado: (2022)

2021 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Shaer, Danah, et al.
Publicado: (2022)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
por: Cho, Su Min, et al.
Publicado: (2022)

Additively manufactured medical products – the FDA perspective
por: Di Prima, Matthew, et al.
Publicado: (2016)

FDA-approved medications that impair human spermatogenesis
por: Ding, Jiayi, et al.
Publicado: (2016)

2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Shaer, Danah, et al.
Publicado: (2020)

2020 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2021)

FDA limits authorised use of Janssen COVID-19 vaccine
Publicado: (2022)

The New CDC Mask Guidance: A Catastrophe for Health Equity
por: Bajaj, Simar Singh, et al.
Publicado: (2021)

Investigators’ Experience With Expedited Safety Reports Prior to the FDA’s Final IND Safety Reporting Rule
por: Kramer, Judith M., et al.
Publicado: (2014)

"Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit"
por: Freire-Paspuel, Byron, et al.
Publicado: (2020)

A Comprehensive Map of FDA-Approved Pharmaceutical Products
por: Zhong, Hao, et al.
Publicado: (2018)

FDA efficiency for approval process of COVID-19 therapeutics
por: Cassidy, Christine, et al.
Publicado: (2020)

The Use of External Controls in FDA Regulatory Decision Making
por: Jahanshahi, Mahta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0g68q29rd0l9aptod2hncg11cg